Clinical Trial Update: The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

View source ↗

Summary

Adenocyte's LINFU U.S. Registry study for patients with pancreatic cancer presenting with signs or symptoms is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• LINFU

Snippet

Sponsor: Adenocyte, LLC | Conditions: Pancreatic Cancer, Jaundice | Status: NOT_YET_RECRUITING